It can inhibit E2F1 to regulate the cell cycle to affect the proliferation of hepatocellular carcinoma and regulate the proliferation of prostate cancer by suppressing ErbB2 (Wang et al., 2014b; Peng et al., 2021). This evidence concerns the gene E2F1 and hepatocellular carcinoma.